SG11201802955VA - Peptides of use in the preventive and curative treatment of alopecia - Google Patents

Peptides of use in the preventive and curative treatment of alopecia

Info

Publication number
SG11201802955VA
SG11201802955VA SG11201802955VA SG11201802955VA SG11201802955VA SG 11201802955V A SG11201802955V A SG 11201802955VA SG 11201802955V A SG11201802955V A SG 11201802955VA SG 11201802955V A SG11201802955V A SG 11201802955VA SG 11201802955V A SG11201802955V A SG 11201802955VA
Authority
SG
Singapore
Prior art keywords
alopecia
preventive
peptides
curative treatment
curative
Prior art date
Application number
SG11201802955VA
Inventor
Michel Hocquaux
Épouse Scalvino Stéphanie Almeida
Elian Lati
Joanna Bakala
Original Assignee
Inst Europeen De Biologie Cellulaire
Centre De Rech Biologiques Et Dexperimentations Cutanees
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Europeen De Biologie Cellulaire, Centre De Rech Biologiques Et Dexperimentations Cutanees, Centre Nat Rech Scient filed Critical Inst Europeen De Biologie Cellulaire
Publication of SG11201802955VA publication Critical patent/SG11201802955VA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0815—Tripeptides with the first amino acid being basic
    • C07K5/0817—Tripeptides with the first amino acid being basic the first amino acid being Arg
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1019—Tetrapeptides with the first amino acid being basic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
SG11201802955VA 2015-10-09 2016-10-10 Peptides of use in the preventive and curative treatment of alopecia SG11201802955VA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1559655A FR3042192B1 (en) 2015-10-09 2015-10-09 PEPTIDES USEFUL IN THE PREVENTIVE AND CURATIVE TREATMENT OF ALOPECIA
PCT/EP2016/074238 WO2017060533A1 (en) 2015-10-09 2016-10-10 Peptides of use in the preventive and curative treatment of alopecia

Publications (1)

Publication Number Publication Date
SG11201802955VA true SG11201802955VA (en) 2018-05-30

Family

ID=55236527

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201802955VA SG11201802955VA (en) 2015-10-09 2016-10-10 Peptides of use in the preventive and curative treatment of alopecia

Country Status (9)

Country Link
US (2) US10947273B2 (en)
EP (1) EP3359554A1 (en)
JP (1) JP6918002B2 (en)
KR (1) KR20180085720A (en)
CN (1) CN108602853B (en)
BR (1) BR112018007119A2 (en)
FR (1) FR3042192B1 (en)
SG (1) SG11201802955VA (en)
WO (1) WO2017060533A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202228757A (en) * 2020-09-24 2022-08-01 日商日本安佳榜化妝股份有限公司 Hair restorer

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2741076B1 (en) 1995-11-15 1998-01-30 Rech De Pathologie Appliquee S PEPTIDE CONJUGATES DERIVED FROM THERMAL HORMONES, THEIR USE AS MEDICAMENTS AND COMPOSITIONS CONTAINING THEM
US6207713B1 (en) * 1997-09-17 2001-03-27 Eric T. Fossel Topical and oral delivery of arginine to cause beneficial effects
AU3863900A (en) * 1999-03-05 2000-09-21 Agnieszka Banbula Prolyl peptidases and methods of use
TWI234460B (en) * 2002-04-03 2005-06-21 Purzer Pharmaceutical Co Ltd Cyclic pentad-peptide and its preparing method
FR2857667B1 (en) * 2003-07-18 2007-07-13 Inst Europ Biolog Cellulaire NEW PEPTIDE CONJUGATES USEFUL IN THE PREVENTIVE AND CURATIVE TREATMENT OF ALOPECIA
FR2857597B1 (en) 2003-07-18 2008-01-25 Inst Europeen Biolog Cellulair USE OF PEPTIDE CONJUGATES FOR THE PREPARATION OF COMPOSITIONS FOR THE PREVENTIVE AND CURATIVE TREATMENT OF ALOPECIA.
US7138491B2 (en) * 2003-10-08 2006-11-21 Guangzhou Bai Yun Shan Pharmaceutical Co., Ltd. Carboline-3-carboxylic acid modified related sequences of Ala-Arg-Pro-Ala-Lys, their synthesis and use as thromobolytic agent
CN101190939B (en) * 2006-11-30 2010-10-13 首都医科大学 Oligopeptide-copper complex with blood vessel extending and thrombus dissolving activity and its preparation method and application
CN102485745B (en) * 2010-12-01 2014-09-03 首都医科大学 Thrombolytic oligopeptides, preparation method and application thereof
CN102807605B (en) * 2011-06-03 2014-06-04 首都医科大学 Nalpha-(1,3-dioxo-4,4,5,5-tetramethylimidazoline-2-phenyl-4'-oxyacetyl)-Nomega-fatty acyl-Lys-Arg-Gly-Asp-Phe and preparation method and application thereof
CN105884905A (en) * 2012-09-05 2016-08-24 上海晟顺生物科技有限公司 Novel compound with thrombolytic, free radical scavenging and thrombus targeted functions, and preparation method and purposes thereof

Also Published As

Publication number Publication date
US20210188911A1 (en) 2021-06-24
CN108602853A (en) 2018-09-28
US10947273B2 (en) 2021-03-16
CN108602853B (en) 2022-05-31
KR20180085720A (en) 2018-07-27
US20180291061A1 (en) 2018-10-11
FR3042192B1 (en) 2017-12-08
FR3042192A1 (en) 2017-04-14
WO2017060533A1 (en) 2017-04-13
EP3359554A1 (en) 2018-08-15
JP2018532774A (en) 2018-11-08
JP6918002B2 (en) 2021-08-11
BR112018007119A2 (en) 2018-11-06

Similar Documents

Publication Publication Date Title
GB201411496D0 (en) Use of 7-Oh-Cannabidiol (7-Oh-CBD) and/or 7-Oh-Cannabidvarin (7-Oh-CBDV) in the treatment of epilepsy
IL261932A (en) Use of probiotics in the treatment and/or prevention of psoriasis
ZA201704726B (en) Peptides and their use in the treatment of skin
ZA201904966B (en) Hydrocarbylsulfonyl-substituted pyridines and their use in the treatment of cancer
ZA201904967B (en) Heteroarylsulfonyl-substituted pyridines and their use in the treatment of cancer
GB201514021D0 (en) Novel Pyridines and their use in the treatment of cancer
IL257577A (en) Novel peptides, combination of peptides and scaffolds for use in immunothera-peutic treatment of various cancers
IL259096A (en) Peptides and methods of treating endometriosis using the same
IL266128B (en) Naphthyridinone derivatives and their use in the treatment of arrhythmia
HK1257585A1 (en) Medicine for preventing and treating skin fibrosis and use of the medicine
IL270978B (en) Grape skin for use in the treatment of dysbiosis
LT3373922T (en) Compositions and methods for use in the treatment of homocystinuria
HUE058652T2 (en) Compounds and their use in the treatment of schistosomiasis
GB201507721D0 (en) Immunosuppressive agents and their use in therapy
EP3518951C0 (en) Compositions for use in the treatment of osteoporis and bone fractures
EP3380112A4 (en) Peptides and their use in the treatment of hair
IL269121A (en) Usl-311 for use in the treatment of cancer
GB201514015D0 (en) Novel pyridazinones and their use in the treatment of cancer
SG11201802955VA (en) Peptides of use in the preventive and curative treatment of alopecia
GB2546965B (en) Improvements in and relating to the treatment of arthrofibrosis
EP3648789C0 (en) Mtmr2-s polypeptide for use in the treatment of myopathies
IL259383A (en) Compound for use in the prevention and treatment of neurodegenerative diseases
PT3526244T (en) Peptides derived from the propeptide ntsr3 and their use in the treatment of depression
PL3262069T3 (en) Use of antibodies and antagonists directed against lrg1 in treatment
TH1801002163A (en) Peptides for use in the treatment, prevention, and remedy of baldness